MasoudMAzizadMD

PubMed

• 207 citations
  A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
  William A Fischer 2nd, Joseph J Eron Jr, Wayne Holman, Myron S Cohen, Lei Fang, Laura J Szewczyk, Timothy P Sheahan, Ralph Baric, Katie R Mollan, Cameron R Wolfe, Eliz...> ;Science Translational Medicine. 2022 Jan 19
• 404 citations
  Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
  Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Ch...> ;The New England Journal of Medicine. 2021 Jul 14
• 19 citations
  A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic...
  Michael Dougan, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Chad Crystal, A...> ;Clinical Infectious Diseases. 2021 Oct 28
• 133 citations
  Molnupiravir, an Oral Antiviral Treatment for COVID-19
  William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang, Laura J. Szewczyk, Timothy P. Sheahan, Ralph S. Baric, Katie R. Mollan, Cameron R. Wolfe, E...> ;Medrxiv. 2021 Jun 17
• Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
  Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators> ;Diabetes care. 2021-03-15
• Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection ...
  Mitchell GF, Solomon SD, Shah AM, Claggett BL, Fang JC, Izzo J, Abbas CA, Desai AS, EVALUATE-HF Investigators*> ;Circulation. Heart failure. 2021-03-05
• SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
  Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, O...> ;The New England journal of medicine. 2020-10-28
• Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
  Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G, FIDELIO-DKD Investigators> ;The New England journal of medicine. 2020-10-23
• Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
  Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B, FIGARO-DKD study investigators> ;American journal of nephrology. 2019-10-30
• Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
  Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G, on behalf of the FIDELIO-DKD study investigators, FIDE...> ;American journal of nephrology. 2019-10-25
• Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSS...
  Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A...> ;The lancet. Diabetes & endocrinology. 2019-07-01
• Use of prostacyclin and its analogues in the treatment of cardiovascular disease.
  Fink, A. N., Frishman, W. H., Azizad, M., Agarwal, Y.> ;Heart Dis. 1999 Mar 01
• Join now to see all